E. Nalbat Et Al. , "Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma," EASL Liver Cancer Summit 2022 , pp.137-138, 2022
Nalbat, E. Et Al. 2022. Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma. EASL Liver Cancer Summit 2022 , 137-138.
Nalbat, E., Akhan Güzelcan, E., Turanlı, S., Lengerli, D., Çalışkan, B., Banoğlu, E., ... Atalay, R.(2022). Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma . EASL Liver Cancer Summit 2022 (pp.137-138).
Nalbat, ESRA Et Al. "Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma," EASL Liver Cancer Summit 2022, 2022
Nalbat, ESRA Et Al. "Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma." EASL Liver Cancer Summit 2022 , pp.137-138, 2022
Nalbat, E. Et Al. (2022) . "Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma." EASL Liver Cancer Summit 2022 , pp.137-138.
@conferencepaper{conferencepaper, author={ESRA NALBAT Et Al. }, title={Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma}, congress name={ EASL Liver Cancer Summit 2022}, city={}, country={}, year={2022}, pages={137-138} }